匹配美国和中国流行基因型的腮腺炎病毒候选疫苗的免疫原性
腮腺炎病毒(MuV)在高度接种人群中仍发生大规模暴发,常用疫苗株Jeryl Lynn属A基因型,已非流行株。研究者开发了匹配美国流行G基因型和中国流行F基因型的两种候选疫苗,发现Jeryl Lynn疫苗对非匹配病毒产生中和抗体反应的能力显著下降,而候选疫苗可能提供更好免疫。
要点
- Jeryl Lynn疫苗株属A基因型,已非当前流行基因型。
- 开发了匹配美国G基因型和中国F基因型的两种候选疫苗。
- Jeryl Lynn疫苗对非匹配病毒的中和抗体反应显著下降。
核心结论
- 数据提示更新疫苗可能对当前流行的MuV G和F基因型提供更好免疫。
研究设计与样本
- 研究开发了两种候选疫苗,分别匹配美国流行G基因型和中国流行F基因型,并与Jeryl Lynn疫苗比较免疫原性。
主要发现
- 与两种候选疫苗相比,Jeryl Lynn疫苗对非匹配病毒产生中和抗体反应的能力显著下降。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mumps virus (MuV) causes acute infection in humans with characteristic swelling of the parotid gland. While vaccination has greatly reduced the incidence of MuV infection, there have been multiple large outbreaks of mumps virus (MuV) in highly vaccinated populations. The most common vaccine strain, Jeryl Lynn, belongs to genotype A, which is no longer a circulating genotype. We have developed two vaccine candidates that match the circulating genotypes in the United States (genotype G) and China (genotype F). We found that there was a significant decrease in the ability of the Jeryl Lynn vaccine to produce neutralizing antibody responses to non-matched viruses, when compared to either of our vaccine candidates. Our data suggests that an updated vaccine may allow for better immunity against the circulating MuV genotypes G and F.
引用
- Zengel J, Phan SI, Pickar A, et al. Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China. Vaccine. 2017. PMID: 28623030. doi:10.1016/j.vaccine.2017.05.084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。